CNMD - CONMED Corporation

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
30/12/2018
30/12/2017
30/12/2016
Cash flows from operating activities
Net income
29,339
40,854
55,487
14,664
Depreciation & amortisation
71,190
61,803
58,548
55,309
Deferred income taxes
-2,175
2,063
-40,021
-2,871
Stock-based compensation
11,391
10,037
8,472
8,375
Change in working capital
-37,435
-44,268
-16,920
-37,255
Accounts receivable
-11,065
-17,460
-13,631
-6,380
Inventory
-17,005
-15,037
-3,926
3,103
Accounts payable
-4,207
12,109
-286
2,094
Other working capital
60,329
58,194
52,724
23,469
Other non-cash items
-
-
-
-280
Net cash provided by operating activities
78,960
74,701
65,566
38,222
Cash flows from investing activities
Investments in property, plant and equipment
-18,631
-16,507
-12,842
-14,753
Acquisitions, net
-364,928
0
-16,212
-256,450
Purchases of investments
-
-
-
-
Sales/maturities of investments
-
-
-
-
Other investing activities
-
-
-
5,178
Net cash used for investing activities
-383,559
-16,507
-29,054
-266,025
Cash flows from financing activities
Debt repayment
-639,855
-182,699
-167,202
-171,097
Common stock issued
-
-
-
-
Common stock repurchased
-
-
-
0
Dividends paid
-22,551
-22,443
-22,307
-22,213
Other financing activities
-90,951
-20,123
-372
-22,488
Net cash used provided by (used for) financing activities
306,210
-72,265
-34,881
184,202
Net change in cash
377
-15,111
5,194
-45,076
Cash at beginning of period
29,691
32,622
27,428
72,504
Cash at end of period
31,302
17,511
32,622
27,428
Free cash flow
Operating cash flow
78,960
74,701
65,566
38,222
Capital expenditure
-18,631
-16,507
-12,842
-14,753
Free cash flow
60,329
58,194
52,724
23,469